The DOI matches its Crossref record; 112 of the 113 references it cites were found in a registry or an index.
Delivery materials for siRNA therapeutics
Abstract
RNA interference (RNAi) has broad potential as a therapeutic to reversibly silence any gene. To achieve the clinical potential of RNAi, delivery materials are required to transport short interfering RNA (siRNA) to the site of action in the cells of target tissues. This Review provides an introduction to the biological challenges that siRNA delivery materials aim to overcome, as well as a discussion of the way that the most effective and clinically advanced classes of siRNA delivery systems, including lipid nanoparticles and siRNA conjugates, are designed to surmount these challenges. The systems that we discuss are diverse in their approaches to the delivery problem, and provide valuable insight to guide the design of future siRNA delivery materials.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Several miRNAs and antisense oligonucleotides (ASOs) are currently under investigation in clinical trials for various diseases (Kanasty et al., 2013;van Rooij and Kauppinen, 2014;Gaudet et al., 2015).”
From microRNA-33 Regulates ApoE Lipidation and Amyloid-β Metabolism in the Brain (2015) · cites this paper as Kanasty et al., 2013
In the citing paper
“The main role of PEGylated lipid in LNPs is to reduce aggregation and non-specific uptake by immune cells.304–306”
From Advances in COVID-19 mRNA vaccine development (2022) · cites this paper as [306]
In the citing paper
“we believe that recent advances in the delivery of nucleic acid therapeutics provide hope that CRISPR-Cas9–mediated correction may be translatable to humans15.”
From Genome editing with Cas9 in adult mice corrects a disease mutation and phenotype (2014) · cites this paper as [15]
Citations
Cites
Atomic structure and chemistry of human serum albumin
He, X. M., & Carter, D. C. (1992) · Nature · doi:10.1038/358209a0 · Cited by 3,833
Factors affecting the clearance and biodistribution of polymeric nanoparticles
Alexis, F., Pridgen, E., Molnar, L. K., & Farokhzad, O. C. (2008) · Molecular Pharmaceutics · doi:10.1021/mp800051m · Cited by 3,699
Strategies in the design of nanoparticles for therapeutic applications
Petros, R. A., & DeSimone, J. M. (2010) · Nature Reviews Drug Discovery · doi:10.1038/nrd2591 · Cited by 3,651
Hannon, G. J. (2002) · Nature · doi:10.1038/418244a · Cited by 3,651
Knocking down barriers: advances in siRNA delivery
Whitehead, K. A., Langer, R., & Anderson, D. G. (2009) · Nature Reviews Drug Discovery · doi:10.1038/nrd2742 · Cited by 3,115
Self-citationAsymmetry in the Assembly of the RNAi Enzyme Complex
Schwarz, D. S., Hutvágner, G., Du, T., Xu, Z., Aronin, N., & Zamore, P. D. (2003) · Cell · doi:10.1016/s0092-8674(03)00759-1 · Cited by 2,922
Evidence of RNAi in humans from systemically administered siRNA via targeted nanoparticles
Davis, M. E., Zuckerman, J. E., Choi, C. H. J., Seligson, D. B., Tolcher, A. W., Alabi, C. A., Yen, Y., Heidel, J. D., & Ribas, A. (2010) · Nature · doi:10.1038/nature08956 · Cited by 2,541
Therapeutic silencing of an endogenous gene by systemic administration of modified siRNAs
Soutschek, J., Akinc, A., Bramlage, B., Charissé, K., Constien, R., Donoghue, M., Elbashir, S. M., Geick, A., Hadwiger, P., Harborth, J., et al. (2004) · Nature · doi:10.1038/nature03121 · Cited by 2,206
Salvati, A., Pitek, A. S., Monopoli, M. P., Prapainop, K., Bombelli, F. B., Hristov, D. R., Kelly, P. M., Åberg, C., Mahon, E., & Dawson, K. A. (2013) · Nature Nanotechnology · doi:10.1038/nnano.2012.237 · Cited by 1,912
Phenotypic Heterogeneity of the Endothelium
Aird, W. C. (2007) · Circulation Research · doi:10.1161/01.res.0000255691.76142.4a · Cited by 1,824
Flagged first, then by citations
1 of the 113 references couldn’t be matched to a known paper.
Cited by
Sorted by citations
Items 901–1,000 of 1,002
Abu‐Laban, M., Kumal, R. R., Casey, J. S., Becca, J. C., LaMaster, D. J., Pacheco, C., Sykes, D. G., Jensen, L., Haber, L. H., & Hayes, D. J. (2018) · Journal of Colloid and Interface Science · doi:10.1016/j.jcis.2018.04.085 · Cited by 26
Suñé-Pou, M., Prieto‐Sánchez, S., Yousfi, Y. E., Boyero-Corral, S., Nardi-Ricart, A., Nofrerias, I., Pérez‐Lozano, P., García‐Montoya, E., Carmona, M. M., Grau, J. R. T., et al. (2018) · International Journal of Nanomedicine · doi:10.2147/ijn.s158884 · Cited by 27
PAMAM-cRGD mediating efficient siRNA delivery to spermatogonial stem cells
Li, T., Chen, Q., Zheng, Y., Zhang, P., Chen, X., Lu, J., Lv, Y., Sun, S., & Zeng, W. (2019) · Stem Cell Research & Therapy · doi:10.1186/s13287-019-1506-4 · Cited by 26
Molla, M. R., Chakraborty, S., Muñoz‐Sagredo, L., Drechsler, M., Orian‐Rousseau, V., & Levkin, P. A. (2020) · Bioconjugate Chemistry · doi:10.1021/acs.bioconjchem.0c00013 · Cited by 26
Attenuated diphtheria toxin mediates siRNA delivery
Arnold, A. E., Smith, L. J., Beilhartz, G. L., Bahlmann, L. C., Jameson, E., Melnyk, R. A., & Shoichet, M. S. (2020) · Science Advances · doi:10.1126/sciadv.aaz4848 · Cited by 26
Self‐Assembled Fluorodendrimers Combine the Features of Lipid and Polymeric Vectors in Gene Delivery
Wang, H., Wang, Y., Wang, Y., Hu, J., Li, T., Liu, H., Zhang, Q., & Cheng, Y. (2015) · Angewandte Chemie · doi:10.1002/ange.201501461 · Cited by 26
Real-Time Fluorescence Tracking of Gene Delivery via Multifunctional Nanocomposites
Bai, M., Bai, X., & Wang, L. (2014) · Analytical Chemistry · doi:10.1021/ac5026489 · Cited by 25
Nanotechnologies for early diagnosis, in situ disease monitoring, and prevention
Wu, T., Chiu, H., Yu, J., Cautela, M. P., Sarmento, B. F. C. C., das Neves, J., Catala, C., Pérez, N. P., Guerrini, L., Álvarez‐Puebla, R. A., et al. (2017) · Elsevier eBooks · doi:10.1016/b978-0-323-48063-5.00001-0 · Cited by 25
Simultaneous and stoichiometric purification of hundreds of oligonucleotides
Pinto, A., Chen, S. X., & Zhang, D. Y. (2018) · Nature Communications · doi:10.1038/s41467-018-04870-w · Cited by 27
Li, C., Li, T., Huang, L., Yang, M., & Zhu, G. (2019) · Chemistry - An Asian Journal · doi:10.1002/asia.201900005 · Cited by 25
Short Interfering RNA (siRNA)-Based Therapeutics for Cartilage Diseases
Zhou, L., Rubin, L. E., Liu, C.-J., & Chen, Y. (2020) · Regenerative Engineering and Translational Medicine · doi:10.1007/s40883-020-00149-z · Cited by 25
Dual-targeting RNA nanoparticles for efficient delivery of polymeric siRNA to cancer cells
Kim, T., Hyun, H. N., Heo, R., Nam, K., Yang, K., Kim, Y. M., Lee, L. Y. S., An, J. Y., Park, J. H., Choi, K. Y., et al. (2020) · Chemical Communications · doi:10.1039/d0cc01848a · Cited by 25
Kaundal, B., Kushwaha, A. C., Srivastava, A. K., Karmakar, S., & Choudhury, S. R. (2020) · Journal of Materials Chemistry B · doi:10.1039/d0tb01177k · Cited by 25
Khan, M. A., Kiser, M. R., Moradipour, M., Nadeau, E. A. W., Ghanim, R. W., Webb, B. A., Rankin, S. E., & Knutson, B. L. (2020) · The Journal of Physical Chemistry B · doi:10.1021/acs.jpcb.0c06536 · Cited by 25
Raynold, A. A. M., Li, D., Chang, L., & Gautrot, J. E. (2021) · Nature Communications · doi:10.1038/s41467-021-26695-w · Cited by 25
A Tubular DNA Nanodevice as a siRNA/Chemo‐Drug Co‐delivery Vehicle for Combined Cancer Therapy
Wang, Z., Song, L., Liu, Q. L., Tian, R., Shang, Y., Liu, F., Liu, S., Zhao, S., Han, Z., Sun, J., et al. (2020) · Angewandte Chemie · doi:10.1002/ange.202009842 · Cited by 25
Zhang, H., Ding, F., Zhu, Z., Sun, Q., & Yang, C. (2022) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2022.122489 · Cited by 25
Liposome encapsulated anticancer drugs on autophagy in cancer cells – Current and future perspective
Bhagya, N., & Chandrashekar, K. R. (2023) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2023.123105 · Cited by 25
Youness, R. A., Mohamed, A. H., Efthimiadou, E. Κ., Mekky, R. Y., Braoudaki, M., & Fahmy, S. A. (2023) · ACS Omega · doi:10.1021/acsomega.3c04134 · Cited by 26
Zhang, Q., Wu, S., Chen, Q., Zhang, Y., Zhang, C., Yin, R., Ouyang, Z., & Wei, Y. (2024) · Biomedicines · doi:10.3390/biomedicines12071505 · Cited by 25
Shakya, A., Dougherty, C. A., Xue, Y., Al‐Hashimi, H. M., & Holl, M. M. B. (2015) · Biomacromolecules · doi:10.1021/acs.biomac.5b01280 · Cited by 25
Immunoliposomes for Targeted Delivery of an Antifibrotic Drug
Schuster, L., Seifert, O., Vollmer, S., Kontermann, R. E., Schlosshauer, B., & Hartmann, H. (2015) · Molecular Pharmaceutics · doi:10.1021/acs.molpharmaceut.5b00012 · Cited by 25
Bone site-specific delivery of siRNA
Xinli, L. (2016) · Journal of Biomedical Research · doi:10.7555/jbr.30.20150110 · Cited by 25
Oliveira, A. C., Fernandes, J., Gonçalves, A., Gomes, A. C., & Oliveira, M. E. C. D. R. (2018) · Current Drug Targets · doi:10.2174/1389450119666180703145410 · Cited by 26
Andreozzi, P., Ricci, C., Porcel, J. E. M., Moretti, P., Silvio, D. D., Amenitsch, H. W., Ortore, M. G., & Moya, S. E. (2019) · Journal of Colloid and Interface Science · doi:10.1016/j.jcis.2019.02.040 · Cited by 25
Karim, M. E., Shetty, J., Islam, R. A., Kaiser, A., Bakhtiar, A., & Chowdhury, E. H. (2019) · Pharmaceutics · doi:10.3390/pharmaceutics11020089 · Cited by 26
Choi, E., Lee, J., Kwon, I. C., Lim, D., & Kim, S. (2019) · Biomaterials · doi:10.1016/j.biomaterials.2019.04.006 · Cited by 25
Engineered Gold Nanoshells Killing Tumor Cells: New Perspectives
Matteis, V. D., Cascione, M., Toma, C. C., & Rinaldi, R. (2019) · Current Pharmaceutical Design · doi:10.2174/1381612825666190618155127 · Cited by 25
Sun, X., Lin, Y., Zhong, X., Fan, C., Liu, Z., Chen, X., Luo, Z., Wu, J., Tima, S., Zhang, Z., et al. (2024) · Journal of Controlled Release · doi:10.1016/j.jconrel.2024.10.002 · Cited by 24
Abdollahzadeh, H., Peeples, T. L., & Shahcheraghi, M. (2025) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2025.115673 · Cited by 26
IRF5 siRNA Nanoimmunotherapy: Restoring Macrophage Efferocytosis in Atherosclerosis
He, Z., Luo, Y., Duan, Z., Su, B., Zeng, W., Guo, Y., Li, Y., He, X., Shi, H., Zhou, Z., et al. (2025) · Circulation · doi:10.1161/circulationaha.125.075352 · Cited by 25
Amino Acid-Functionalized Dendritic Polyglycerol for Safe and Effective siRNA Delivery
Zeng, H., Schlesener, C., Cromwell, O. R., Hellmund, M., Haag, R., & Guan, Z. (2015) · Biomacromolecules · doi:10.1021/acs.biomac.5b01196 · Cited by 24
Wang, Y., Yu, Z., Zhang, Z., Ren, R., & Zhang, S. (2016) · The Analyst · doi:10.1039/c6an00160b · Cited by 24
Lipid‑based nanoparticles for the therapeutic delivery of non‑coding RNAs in breast cancer (Review)
Silva-Cázares, M. B., Saavedra-Leos, M. Z., Jordan‐Alejandre, E., Núñez-Olvera, S. I., Martínez, I. C., & López‐Camarillo, C. (2020) · Oncology Reports · doi:10.3892/or.2020.7791 · Cited by 24
Lokras, A. G., Thakur, A., Wadhwa, A., Thanki, K., Franzyk, H., & Foged, C. (2021) · Frontiers in Bioengineering and Biotechnology · doi:10.3389/fbioe.2020.601155 · Cited by 24
CRISPR-derived genome editing therapies: Progress from bench to bedside
Rees, H. A., Minella, A. C., Burnett, C. A., Komor, A. C., & Gaudelli, N. M. (2021) · Molecular Therapy · doi:10.1016/j.ymthe.2021.09.027 · Cited by 25
Kiani, F. K., Izadi, S., Dezfouli, E. A., Ebrahimi, F., Mohammadi, M. K., Chalajour, H., Bulus, M. M., Esfahani, M. N., Karpisheh, V., Khesht, A. M. S., et al. (2021) · Life Sciences · doi:10.1016/j.lfs.2021.120166 · Cited by 24
RetractedSequence‐Defined Oligomers from Hydroxyproline Building Blocks for Parallel Synthesis Applications
Kanasty, R. L., Vegas, A. J., Ceo, L. M., Maier, M. A., Charissé, K., Nair, J. K., Langer, R., & Anderson, D. G. (2016) · Angewandte Chemie · doi:10.1002/ange.201602748 · Cited by 24
Self-citationNonviral Delivery of CRISPR/Cas Systems in mRNA Format
Liu, Z., Li, Z., & Li, B. (2022) · Advanced NanoBiomed Research · doi:10.1002/anbr.202200082 · Cited by 25
Wang, J., Mao, K., Cong, X., Tan, H., Wu, C., Hu, Z., Yang, Y.-G., & Sun, T. (2022) · Science Advances · doi:10.1126/sciadv.abq3699 · Cited by 24
Qin, Y., Walters, A. A., Rouatbi, N., Wang, J. T.-W., Abdel‐Bar, H. M., & Al‐Jamal, K. T. (2023) · Biomaterials · doi:10.1016/j.biomaterials.2023.122158 · Cited by 24
Advancing Cancer Immunotherapy: The Potential of mRNA Vaccines As a Promising Therapeutic Approach
Goyal, F., Chattopadhyay, A., Navik, U., Jain, A., Reddy, P. H., Bhatti, G. K., & Bhatti, J. S. (2023) · Advanced Therapeutics · doi:10.1002/adtp.202300255 · Cited by 25
Bacchi, N., Casarosa, S., & Denti, M. A. (2014) · Investigative Ophthalmology & Visual Science · doi:10.1167/iovs.14-14544 · Cited by 24
Lellouche, E., Israel, L. L., Bechor, M., Attal, S., Kurlander, E., Asher, V. A., Dolitzky, A., Shaham, L., Izraeli, S., Lellouche, J., et al. (2015) · Bioconjugate Chemistry · doi:10.1021/acs.bioconjchem.5b00276 · Cited by 24
Scaggiante, B., Farra, R., Dapas, B., Baj, G., Pozzato, G., Grassi, M., Zanconati, F., & Grassi, G. (2016) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2016.04.031 · Cited by 24
Engineering galectin–glycan interactions for immunotherapy and immunomodulation
Farhadi, S. A., & Hudalla, G. A. (2016) · Experimental Biology and Medicine · doi:10.1177/1535370216650055 · Cited by 24
Bioresponsive Polymer-Based Nucleic Acid Carriers
Takemoto, H., Miyata, K., Nishiyama, N., & Kataoka, K. (2014) · Advances in genetics · doi:10.1016/b978-0-12-800148-6.00010-9 · Cited by 24
Therapeutic editing of hepatocyte genome in vivo
de Galarreta, M. R., & Lujambio, A. (2017) · Journal of Hepatology · doi:10.1016/j.jhep.2017.05.012 · Cited by 25
Zhang, Y., Zhou, Z., & Chen, M. (2018) · Polymers · doi:10.3390/polym10040379 · Cited by 24
Liu, T., Chen, S., Zhang, S., Wu, X., Wu, P., Miao, B., & Cai, X. (2018) · Journal of Materials Chemistry B · doi:10.1039/c8tb00489g · Cited by 24
Chen, M., Wang, L., Wang, F., Li, F., Xia, W., Gu, H., & Chen, Y. (2019) · International Journal of Nanomedicine · doi:10.2147/ijn.s198511 · Cited by 24
Digiacomo, L., Giulimondi, F., Mahmoudi, M., & Caracciolo, G. (2019) · Nanoscale Advances · doi:10.1039/c9na00195f · Cited by 25
Sequence-Defined Dithiocarbamate Oligomers via a Scalable, Support-free, Iterative Strategy
Nanjan, P., Jose, A., Thurakkal, L., & Porel, M. (2020) · Macromolecules · doi:10.1021/acs.macromol.0c00412 · Cited by 24
Zhang, M., Wang, Y., Li, B., Yang, B., Zhao, M., Li, B., Liu, J., Hu, Y., Wu, Z., Ong, Y., et al. (2024) · Advanced Materials · doi:10.1002/adma.202412654 · Cited by 23
How to Tackle the Challenge of siRNA Delivery with Sequence‐Defined Oligoamino Amides
Reinhard, S., & Wagner, E. (2016) · Macromolecular Bioscience · doi:10.1002/mabi.201600152 · Cited by 23
Biodegradable cationic nanogels with tunable size, swelling and pKa for drug delivery
Spencer, D. S., Shodeinde, A. B., Beckman, D. W., Luu, B. C., Hodges, H. R., & Peppas, N. A. (2020) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2020.119691 · Cited by 23
Li, Y., Tan, Y., Wen, L., Xing, Z., Wang, C., Zhang, L., Wu, K., Sun, H., Li, Y., Lei, Q., et al. (2021) · Molecular Therapy — Nucleic Acids · doi:10.1016/j.omtn.2021.09.011 · Cited by 23
Zhang, X., Qin, B., Wang, M., Feng, J., Zhang, C., Zhu, C., He, S., Liu, H., Wang, Y., Averick, S. E., et al. (2022) · International Journal of Nanomedicine · doi:10.2147/ijn.s340926 · Cited by 23
Chen, D., Zhang, P., Li, M., Li, C., Lu, X., Sun, Y., & Sun, K. (2022) · Drug Delivery · doi:10.1080/10717544.2022.2032874 · Cited by 23
Chen, X., Ye, Q., Chen, Z., Qian, L., Chen, W., Xie, C., & Wang, X. (2022) · Bioengineered · doi:10.1080/21655979.2022.2074703 · Cited by 23
Why is Mortalin a Potential Therapeutic Target for Cancer?
Yoon, A. R., Wadhwa, R., Kaul, S. C., & Yun, C. (2022) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2022.914540 · Cited by 27
Osteomyelitis and non-coding RNAS: A new dimension in disease understanding
Hussain, M. S., Shaikh, N. K., Agrawal, M., Tufail, M., Bisht, A. S., Khurana, N., & Kumar, R. (2024) · Pathology - Research and Practice · doi:10.1016/j.prp.2024.155186 · Cited by 23
Kabir, A. U., Lee, T. J., Pan, H., Berry, J. C., Krchma, K., Wu, J. H., Liu, F., Kang, H., Hinman, K., Yang, L., et al. (2018) · JCI Insight · doi:10.1172/jci.insight.97349 · Cited by 23
The development of tertiary amine cationic lipids for safe and efficient siRNA delivery
Lin, Z., Bao, M., Yu, Z., Xue, L., Ju, C., & Zhang, C. (2019) · Biomaterials Science · doi:10.1039/c9bm00494g · Cited by 23
Zhou, K., Johnson, L. T., Xiong, H., Barrios, S., Minnig, J. T., Yan, Y., Abram, B., Yu, X., & Siegwart, D. J. (2020) · Molecular Pharmaceutics · doi:10.1021/acs.molpharmaceut.9b01288 · Cited by 23
Ali, H. M., Urbinati, G., Chapuis, H., Desmaële, D., Bertrand, J., Couvreur, P., & Massaad-Massade, L. (2014) · PLoS ONE · doi:10.1371/journal.pone.0095964 · Cited by 23
Bai, L., & Su, P. (2025) · Frontiers in Immunology · doi:10.3389/fimmu.2025.1718256 · Cited by 23
“Programmed packaging” for gene delivery
Hyodo, M., Sakurai, Y., Akita, H., & Harashima, H. (2014) · Journal of Controlled Release · doi:10.1016/j.jconrel.2014.04.023 · Cited by 23
Dumitru, A. C., Herruzo, E. T., Rausell, E., Ceña, V., & Garcia, R. A. (2015) · Nanoscale · doi:10.1039/c5nr04906g · Cited by 22
Kim, B. S., Naito, M., Chaya, H., Hori, M., Hayashi, K., Min, H. S., Yi, Y., Kim, H. J., Nagata, T., Anraku, Y., et al. (2020) · Biomacromolecules · doi:10.1021/acs.biomac.0c01192 · Cited by 22
Zhang, X., Hong, K., Sun, Q., Zhu, Y., & Du, J. (2021) · Biomaterials Science · doi:10.1039/d1bm00643f · Cited by 22
Chakraborty, K., Biswas, A., Mishra, S., Mallick, A. M., Tripathi, A., Jan, S., & Roy, R. S. (2023) · ACS Applied Bio Materials · doi:10.1021/acsabm.2c00726 · Cited by 22
Nanomaterials modulate tumor-associated macrophages for the treatment of digestive system tumors
Li, H., Wang, S., Yang, Z., Meng, X., & Niu, M. (2024) · Bioactive Materials · doi:10.1016/j.bioactmat.2024.03.003 · Cited by 22
siRNA therapy in osteoarthritis: targeting cellular pathways for advanced treatment approaches
Li, Y., Zhao, J., Guo, S., & He, D. (2024) · Frontiers in Immunology · doi:10.3389/fimmu.2024.1382689 · Cited by 22
Engineering better immunotherapies via RNA interference
Sioud, M. (2014) · Human Vaccines & Immunotherapeutics · doi:10.4161/hv.29754 · Cited by 22
A novel multifunctional biomimetic Au@BSA nanocarrier as a potential siRNA theranostic nanoplatform
Wang, Z., Hui, W., Shi, H., Wang, M., Huang, C., & Jia, N. (2016) · Journal of Materials Chemistry B · doi:10.1039/c5tb02326b · Cited by 22
Zhang, Z., Jiao, Y., Wang, Y., & Zhang, S. (2016) · Scientific Reports · doi:10.1038/srep29872 · Cited by 22
Quantum dot‐mediated delivery of siRNA to inhibit sphingomyelinase activities in brain‐derived cells
Getz, T. M., Qin, J., Medintz, I. L., Delehanty, J. B., Susumu, K., Dawson, P. E., & Dawson, G. (2016) · Journal of Neurochemistry · doi:10.1111/jnc.13841 · Cited by 22
Tuning the pH‐Switch of Supramolecular Polymer Carriers for siRNA to Physiologically Relevant pH
Ahlers, P., Frisch, H., Holm, R., Spitzer, D., Barz, M., & Besenius, P. (2017) · Macromolecular Bioscience · doi:10.1002/mabi.201700111 · Cited by 22
Wang, R., Zhao, Z., Han, Y., Hu, S., Opoku‐Damoah, Y., Zhou, J., Yin, L., & Ding, Y. (2017) · Molecular Pharmaceutics · doi:10.1021/acs.molpharmaceut.7b00192 · Cited by 22
Lv, M.-M., Wu, Z., Yu, R., & Jiang, J. (2020) · Chemical Communications · doi:10.1039/d0cc01626h · Cited by 22
Core-Crosslinked Fluorescent Worm-Like Micelles for Glucose-Mediated Drug Delivery
Elter, J. K., Quader, S., Eichhorn, J., Gottschaldt, M., Kataoka, K., & Schacher, F. H. (2021) · Biomacromolecules · doi:10.1021/acs.biomac.0c01661 · Cited by 22
Hong, S., Zhang, X., Chen, J., Zhou, J., Zheng, Y., & Xu, C. (2013) · Journal of Ovarian Research · doi:10.1186/1757-2215-6-80 · Cited by 22
Oral nucleic acid therapy using multicompartmental delivery systems
Attarwala, H. Z., Han, M., Kim, J., & Amiji, M. M. (2017) · Wiley Interdisciplinary Reviews Nanomedicine and Nanobiotechnology · doi:10.1002/wnan.1478 · Cited by 24
Sun, Y., Liu, Y., Li, R., Zhang, C., Wu, M., Zhang, X., Zheng, A., Liao, N., Zheng, Y., Xu, H., et al. (2024) · Advanced Science · doi:10.1002/advs.202400951 · Cited by 21
Treatment of KRAS-Mutated Pancreatic Cancer: New Hope for the Patients?
Krupa, K., Fudalej, M. M., Włoszek, E., Miski, H., Badowska-Kozakiewicz, A. M., Mękal, D., Budzik, M. P., Czerw, A. I., & Deptała, A. (2025) · Cancers · doi:10.3390/cancers17152453 · Cited by 21
Gene and Cell Doping: The New Frontier - Beyond Myth or Reality
Neuberger, E. W. I., & Simon, P. D. (2017) · Medicine and sport science/Medicine and sport · doi:10.1159/000465456 · Cited by 21
Li, Y., Boetker, J. P., Rantanen, J., Yang, M., & Bohr, A. (2020) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2020.119388 · Cited by 21
Vincentis, A. D., Rahmani, Z., Muley, M., Gentilucci, U. V., Ruggiero, S., Zamani, P., Jamialahmadi, T., & Sahebkar, A. (2020) · Drug Discovery Today · doi:10.1016/j.drudis.2020.05.009 · Cited by 21
SHROOM3, the gene associated with chronic kidney disease, affects the podocyte structure
Matsuura, R., Hiraishi, A., Holzman, L. B., Hanayama, H., Harano, K., Nakamura, E., Hamasaki, Y., Doi, K., Nangaku, M., & Noiri, E. (2020) · Scientific Reports · doi:10.1038/s41598-020-77952-9 · Cited by 21
Small RNAs: An expanding world with therapeutic promises
Gou, L., Zhu, Q., & Liu, M. (2023) · Fundamental Research · doi:10.1016/j.fmre.2023.03.003 · Cited by 22
Xia, B., Liu, Y., Wang, J., Lu, Q., Lv, X., Deng, K., & Yang, J. (2023) · Pharmacological Research · doi:10.1016/j.phrs.2023.106880 · Cited by 21
Exosomal MicroRNAs: An Emerging Important Regulator in Acute Lung Injury
Lan, B., Dong, X., Yang, Q., Luo, Y., Wen, H., Chen, Z., & Chen, H. (2023) · ACS Omega · doi:10.1021/acsomega.3c04955 · Cited by 21
Updates in Small Interfering RNA for the Treatment of Dyslipidemias
Carugo, S., Sirtori, C. R., Gelpi, G., Corsini, A., Tokgözoğlu, L. S., & Ruscica, M. (2023) · Current Atherosclerosis Reports · doi:10.1007/s11883-023-01156-5 · Cited by 22
Huang, X., & Zhang, W. (2023) · Small Methods · doi:10.1002/smtd.202301326 · Cited by 21
Liu, Y., Wang, Y., Liu, B., Liu, W., Ma, Y., Cao, Y., Shi, Y., Zhang, P., Zhou, L., Zhan, Q., et al. (2023) · Science China Life Sciences · doi:10.1007/s11427-023-2434-8 · Cited by 21
Diagnostic and mechanistic roles of MicroRNAs in neurodevelopmental & neurodegenerative disorders
Khoodoruth, M. A. S., Khoodoruth, W. N. C., Uroos, M., Alabdulla, M., Khan, Y. S., & Mohammad, F. (2024) · Neurobiology of Disease · doi:10.1016/j.nbd.2024.106717 · Cited by 21
Guo, J., Rahme, K., Fitzgerald, K. A., Holmes, J. D., & O’Driscoll, C. M. (2015) · Nano Research · doi:10.1007/s12274-015-0829-4 · Cited by 21
Gao, H., Takemoto, H., Chen, Q., Naito, M., Uchida, H., Liu, X., Miyata, K., & Kataoka, K. (2015) · Chemical Communications · doi:10.1039/c4cc09859e · Cited by 21
A novel peptide for efficient siRNA delivery in vitro and therapeutics in vivo
Ran, P., Xu, W., Yuan, F., Chu, D., Ding, Y., Chen, B., Jafari, M., Yuan, Y., & Chen, P. (2015) · Acta Biomaterialia · doi:10.1016/j.actbio.2015.04.002 · Cited by 21
Metadata
- Authors
- Kanasty, R., Dorkin, J. R., Vegas, A., & Anderson, D.
- Affiliations
- Koch Institute for Integrative Cancer Research At MIT (US)
- Boston Children's Hospital (US)
- Corresponding author
- Anderson, Daniel
- Venue
- Nature Materials
- Published
- 2013-10-23
- Volume
- 12
- Issue
- 11
- Pages
- 967-977
- ISSN
- 1476-1122 (ISSN-L)
- 1476-4660
- OpenAlex
- W1995770815
- Cited by
- 1,800
- References
- 113
- Citations by year
- 2026: 77 · 2025: 103 · 2024: 111 · 2023: 138 · 2022: 139 · 2021: 148 · 2020: 159 · 2019: 129 · 2018: 164 · 2017: 151 · 2016: 183 · 2015: 179 · 2014: 114 · 2013: 4
- FWCI
- 15.04
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Nature Materials (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › RNA Interference and Gene Delivery
- Physical Sciences › Materials Science › Biomaterials › Nanoparticle-Based Drug Delivery
- Physical Sciences › Materials Science › Polymers and Plastics › Dendrimers and Hyperbranched Polymers
- Keywords
- siRNA delivery, RNA interference therapy, lipid nanoparticles, siRNA conjugates, gene silencing, drug delivery materials
- MeSH terms
- Animals, Drug Carriers, Humans, RNA, Small Interfering, Nanoparticles
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review